Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV

NCT04437017 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

557

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Olanzapine+NK-1 RA+5-HT3 RA
DRUG: Dexamethasone+NK-1 RA+5-HT3 RA

Sponsor

Fifth Affiliated Hospital, Sun Yat-Sen University